
What smart money is saying about HOYA Corporation
1 fund in our archive has pitched HOYA Corporation — most recently Platinium Asset Management in December 2025.
HOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and medical related products, such as prosthetic ceramic fillers and metallic implants. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke that is a time and attendance management service, and Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.
Get an email when a fund writes about it
Fund coverage · 1 thesis
- Platinium Asset ManagementDecember 2025
HOYA leverages optical glass leadership into high-margin EUV mask blanks and HDD glass substrates, with potential upside from smart glasses and disciplined returns.
Read the full thesis
Read every full thesis on HOYA Corporation
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→